معرفی
Associate Professor Nicholas Fuller is a prominent obesity researcher at The University of Sydney, serving as Clinical Trials Director within the Department of Endocrinology at Royal Prince Alfred Hospital and as a member of the Boden Initiative. His work bridges academic research and practical applications in weight management, with a focus on developing sustainable approaches to obesity treatment and prevention that consider the complex biological, psychological, and economic factors involved.
Dr. Fuller's research interests center on preventing weight regain after dieting, a critical challenge in obesity management. He has developed the scientifically-proven Interval Weight Loss (IWL) program, which addresses the body's evolutionary resistance to sustained weight loss by incorporating strategic maintenance periods between weight loss phases. His work spans clinical trials, health economics, dietary interventions, and behavioral approaches to obesity treatment, with particular emphasis on translating research into real-world applications that improve population health.
Analysis of his recent publications reveals a strong focus on evidence-based approaches to weight management, with significant contributions to understanding the effectiveness of dietary supplements, clinical assessment protocols for obesity, and economic factors influencing weight loss success. His research consistently appears in top medical journals including The Lancet, JAMA Network Open, and American Journal of Clinical Nutrition, with six of his top 10 publications ranking in the top 5% of all research outputs scored by Altmetric.
- Wentworth medal - The University of Sydney
- Accepted into the prestigious Incubate program - The University of Sydney
- Awarded the 'People's Choice Award' - Genesis, The University of Sydney
- University of Sydney Genesis Prize
- Awards from the Chancellor's Committee at the University of Sydney for research impact
Dr. Fuller has secured significant funding for investigating diverse obesity interventions including dietary & exercise programs, complementary medicines, commercial weight loss programs, pharmaceutical drugs, medical devices, bariatric surgery, satiety hormones, and obesity economics. His work has resulted in policy changes in obesity management and has been featured in over 1,000 media appearances across television, radio, and print media. As a consultant for industry and government organizations, he provides expert guidance on obesity treatment approaches and has been ranked as the number 1 author on The Conversation in 2024.
As Clinical Trials Director at the Charles Perkins Centre, Dr. Fuller leads research initiatives that combine cutting-edge technology with clinical expertise to develop innovative obesity treatments. His team provides comprehensive clinical analysis services from study design through to media dissemination, working with a broad portfolio of clients to evaluate emerging obesity treatments and technologies.
